Press release
Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | Artelo Biosciences, Hoffmann-La Roche, Ananda Scientific, Longboard Pha
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cnnabinoid Receptor Type 2 (CB2) Agonist pipeline constitutes key companies continuously working towards developing Cnnabinoid Receptor Type 2 (CB2) Agonist treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Cnnabinoid Receptor Type 2 (CB2) Agonist Market.
The Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Report: https://www.delveinsight.com/sample-request/Cnnabinoid-receptor-type-2-cb2-agonist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Cnnabinoid Receptor Type 2 (CB2) Agonist treatment therapies with a considerable amount of success over the years.
• Cnnabinoid Receptor Type 2 (CB2) Agonist companies working in the treatment market are Artelo Biosciences, Hoffmann-La Roche, Ananda Scientific, Longboard Pharmaceuticals, Emerald Health Pharmaceuticals, Centrexion Therapeutics, Bionorica SE, Vertanical GmbH, Corbus Pharmaceuticals Inc., and others, are developing therapies for the Cnnabinoid Receptor Type 2 (CB2) Agonist treatment
• Emerging Cnnabinoid Receptor Type 2 (CB2) Agonist therapies in the different phases of clinical trials are- ART27.13, RG-7774, A-1002-N5S, LP 143, EHP 102, CNTX-6016, BX-1, VER-01, Lenabasum, and others are expected to have a significant impact on the Cnnabinoid Receptor Type 2 (CB2) Agonist market in the coming years.
Cnnabinoid Receptor Type 2 (CB2) Agonist Overview
The endoCnnabinoid system, which includes Cnnabinoid receptors spread throughout the body, is implicated in numerous physiological functions. The Cnnabinoid system is still being studied as a potential therapeutic target. The Cnnabinoid type 2 (CB2) receptor appears to be free of unwanted psychotropic effects and addiction risk, and it is mostly expressed only when there is active inflammation.
Get a Free Sample PDF Report to know more about Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/Cnnabinoid-receptor-type-2-cb2-agonist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Emerging Cnnabinoid Receptor Type 2 (CB2) Agonist Drugs Under Different Phases of Clinical Development Include:
• LP 143: Longboard Pharmaceuticals
• EHP 102: Emerald Health Pharmaceuticals
• CNTX-6016: Centrexion Therapeutics
• ART27.13: Artelo Biosciences
• RG-7774: Hoffmann-La Roche
• A-1002-N5S: Ananda Scientific
• BX-1: Bionorica SE
• VER-01: Vertanical GmbH
• Lenabasum: Corbus Pharmaceuticals Inc.
Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Therapeutics Assessment
• Cnnabinoid Receptor Type 2 (CB2) Agonist Assessment by Product Type
• Cnnabinoid Receptor Type 2 (CB2) Agonist By Stage and Product Type
• Cnnabinoid Receptor Type 2 (CB2) Agonist Assessment by Route of Administration
• Cnnabinoid Receptor Type 2 (CB2) Agonist By Stage and Route of Administration
• Cnnabinoid Receptor Type 2 (CB2) Agonist Assessment by Molecule Type
• Cnnabinoid Receptor Type 2 (CB2) Agonist by Stage and Molecule Type
DelveInsight's Cnnabinoid Receptor Type 2 (CB2) Agonist Report covers around products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Cnnabinoid Receptor Type 2 (CB2) Agonist product details are provided in the report. Download the Cnnabinoid Receptor Type 2 (CB2) Agonist pipeline report to learn more about the emerging Cnnabinoid Receptor Type 2 (CB2) Agonist therapies at:
https://www.delveinsight.com/sample-request/Cnnabinoid-receptor-type-2-cb2-agonist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key companies in the Cnnabinoid Receptor Type 2 (CB2) Agonist Therapeutics Market include:
Key companies developing therapies for Cnnabinoid Receptor Type 2 (CB2) Agonist are - Insys Therapeutics, Bausch Health, GW Pharmaceuticals, Corbus Pharmaceuticals, and others.
Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Analysis:
The Cnnabinoid Receptor Type 2 (CB2) Agonist pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Cnnabinoid Receptor Type 2 (CB2) Agonist with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Cnnabinoid Receptor Type 2 (CB2) Agonist Treatment.
• Cnnabinoid Receptor Type 2 (CB2) Agonist key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Cnnabinoid Receptor Type 2 (CB2) Agonist Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Cnnabinoid Receptor Type 2 (CB2) Agonist market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Cnnabinoid Receptor Type 2 (CB2) Agonist drugs and therapies-
https://www.delveinsight.com/sample-request/Cnnabinoid-receptor-type-2-cb2-agonist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Market Drivers
• Increasing R&D Investments, A novel target for the treatment or management of a range of painful conditions, lacks unwanted side effects of CB1 activation are some of the important factors that are fueling the Cnnabinoid Receptor Type 2 (CB2) Agonist Market.
Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Market Barriers
• However, require additional investigation to translate the preclinical potential of CB2Rs and their ligands to the clinical scenario, the cell types expressing CB2 that mediate the effects remain poorly understood and other factors are creating obstacles in the Cnnabinoid Receptor Type 2 (CB2) Agonist Market growth.
Scope of Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Drug Insight
• Coverage: Global
• Key Cnnabinoid Receptor Type 2 (CB2) Agonist Companies: Artelo Biosciences, Hoffmann-La Roche, Ananda Scientific, Longboard Pharmaceuticals, Emerald Health Pharmaceuticals, Centrexion Therapeutics, Bionorica SE, Vertanical GmbH, Corbus Pharmaceuticals Inc., and others
• Key Cnnabinoid Receptor Type 2 (CB2) Agonist Therapies: ART27.13, RG-7774, A-1002-N5S, LP 143, EHP 102, CNTX-6016, BX-1, VER-01, Lenabasum, and others
• Cnnabinoid Receptor Type 2 (CB2) Agonist Therapeutic Assessment: Cnnabinoid Receptor Type 2 (CB2) Agonist current marketed and Cnnabinoid Receptor Type 2 (CB2) Agonist emerging therapies
• Cnnabinoid Receptor Type 2 (CB2) Agonist Market Dynamics: Cnnabinoid Receptor Type 2 (CB2) Agonist market drivers and Cnnabinoid Receptor Type 2 (CB2) Agonist market barriers
Request for Sample PDF Report for Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/Cnnabinoid-receptor-type-2-cb2-agonist-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Cnnabinoid Receptor Type 2 (CB2) Agonist Report Introduction
2. Cnnabinoid Receptor Type 2 (CB2) Agonist Executive Summary
3. Cnnabinoid Receptor Type 2 (CB2) Agonist Overview
4. Cnnabinoid Receptor Type 2 (CB2) Agonist- Analytical Perspective In-depth Commercial Assessment
5. Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Therapeutics
6. Cnnabinoid Receptor Type 2 (CB2) Agonist Late Stage Products (Phase II/III)
7. Cnnabinoid Receptor Type 2 (CB2) Agonist Mid Stage Products (Phase II)
8. Cnnabinoid Receptor Type 2 (CB2) Agonist Early Stage Products (Phase I)
9. Cnnabinoid Receptor Type 2 (CB2) Agonist Preclinical Stage Products
10. Cnnabinoid Receptor Type 2 (CB2) Agonist Therapeutics Assessment
11. Cnnabinoid Receptor Type 2 (CB2) Agonist Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Cnnabinoid Receptor Type 2 (CB2) Agonist Key Companies
14. Cnnabinoid Receptor Type 2 (CB2) Agonist Key Products
15. Cnnabinoid Receptor Type 2 (CB2) Agonist Unmet Needs
16 . Cnnabinoid Receptor Type 2 (CB2) Agonist Market Drivers and Barriers
17. Cnnabinoid Receptor Type 2 (CB2) Agonist Future Perspectives and Conclusion
18. Cnnabinoid Receptor Type 2 (CB2) Agonist Analyst Views
19. Appendix
20. About DelveInsight
Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market
Ventricular Assist Devices Market By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devcies And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of heart failure and cardiovascular diseases due to obesity, age, & unhealthy lifestyles and rising demand for organ transplants due to increasing prevalence of chronic ailments such as hypertension, diabetes, and others
B-cell Non-hodgkin Lymphoma Market https://www.delveinsight.com/report-store/b-cell-non-hodgkin-lymphoma-market
DelveInsight's "B-Cell Non-Hodgkin Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the B-Cell Non-Hodgkin Lymphoma, historical and forecasted epidemiology as well as the B-Cell Non-Hodgkin Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.
Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.
Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.
Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.
Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.
Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+91-9650213330
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | Artelo Biosciences, Hoffmann-La Roche, Ananda Scientific, Longboard Pha here
News-ID: 3329476 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Type
Pressure Pumping Market 2028 By Type, Well Type, Resource Type and Geography
The Insight Partners delivers well-researched industry-wide information on the Pressure Pumping market. It provides information on the market's essential aspects such as top participants, factors driving Pressure Pumping market growth, precise estimation of the Pressure Pumping market size, upcoming trends, changes in consumer behavioral pattern, market's competitive landscape, key market vendors, and other market features to gain an in-depth analysis of the market. Additionally, the report is a compilation of…
Lawn Mowers Market Analysis By Type, End User, Product Type, Fuel Type, Engine P …
Lawn Mowers Market Analysis By Type(Manual, Electric, Petrol, Robotic), By End User(Residential, Commercial), By Product Type(Walk behind Movers, Ride on Movers, Stand on Movers), By Fuel Type(Gas Powered, Propane Powered), By Engine Power(Less than 15 hp, Between 15hp and 30 hp, More than 30 hp), By Blade Type(Cylinder, Standard, Mulching, Lifting), By Drive Type(AWD, FWD, RWD), By Application(Residential, Professional landscaping, Golf Course, Government), By Distribution Channel(Retail Store, Online Website) &…
Automotive Exhaust System Component Market Type, Fuel Type, Treatment Device, Ve …
Automotive Exhaust System Component Market
This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
Tenneco
Faurecia
Eberspacher
Boysen
Sango
HITER
Yutaka Giken
Calsonic Kansei
Magneti Marelli
Benteler
Sejong Industrial
Katcon
Futaba
Wanxiang
Bosal
Harbin Airui
Dinex
Catar
DSM
Get Sample PDF including full TOC, Tables and Figures @ https://www.ozonemarketreports.com/automotive-and-transportation/global-automotive-exhaust-system-components-market-professional-survey-report-2019/59563
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Exhaust Manifold
Exhaust Pipe
Catalytic Converter
Exhaust Temperature Sensor
Car Muffler
Exhaust…
Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,…
Automotive Electric Vacuum Pump Market By Type Diaphragm Type, Swing Piston Type …
Automatic electric vacuum pump is a device that gets the drive from the camshaft in the engine. It can also be run by alternator shaft in some designs. It’s an added benefit to any engine, which has high performance. The primary function of an automatic electric vacuum pump is to drain out the air from brake booster tank hence creating the vacuum, which in turn can be used for application…
Marine Composites Market |By Type |Resin Type|Vessel Type|Fiber Type |Region Ana …
The report includes market segmentation by composites type (metal matrix composite, ceramic matrix composite, polymer matrix composite); polymer matrix composite by fiber type (glass fiber, carbon fiber, others); polymer matrix composite by resin type (polyester, vinyl ester, epoxy, thermoplastic, others); vessel type (power boats, sailboats, cruise ships, others); and region (North America, Europe, APAC, Latin America, MEA).
Download Latest Free PDF Sample Brochure of “Marine Composites Market” With Detailed TOC…
